The Development of the Biological Evaluation on Medical Device in 2003

Ting-fei XI

DOI: https://doi.org/10.3969/j.issn.1006-6586.2003.06.012

2003-01-01

Abstract:This paper largely introduces ISO/TC194 annual meeting, and also presents the new development of the Biological Evaluation on Medical Device in 2003.

What problem does this paper attempt to address?

Expert Consensus on Quality Management System of Bioprinting Medical Devices Special Requirements

Tao Li,Dezhi Lu,Ya Ren,Tianchang Wang,Yuanjing Xu,Zhenjiang Ma,Xin Sun,Lei Qiang,Xue Yang,Guohong Shi,Tao Xu,Neng Xie,Ming Guo,Qingfeng Zeng,Jian Sun,Xiaodong Cao,Bo Zhang,Yong He,Maling Gou,Baolin Li,Miao Zhou,Weijie Peng,Lei Hou,Keqin Zhang,Xin Jiang,Xi Yang,Chungkuang Chen,Jinwu Wang,Kerong Dai

DOI: https://doi.org/10.4103/digm.digm_37_21

2022-01-01

Digital Medicine

Abstract:Bioprinting is expected to be a revolutionary technology for application in medicine, bringing hope to countless patients. For a long time, many patients have been experiencing a lack of suitable organs for transplantation, which eventually lead to loss of lives. Bioprinting technology can integrate cells, proteins, cytokines, and other supporting materials, such as biomaterials and hydrogels, to produce biomedical devices with biological functions. However, no bioprinting medical devices have been approved by the National Medical Products Administration, with specific registration and regulatory requirements for bioprinting medical devices still needing to be explored. To standardize the Bioprinting Medical Devices Special Requirements for Quality Management System, Chinese experts in relevant fields were organized to formulate this expert consensus.
Biological evaluation standard and trial method of biomaterials

Xi Tingfei

DOI: https://doi.org/10.3969/j.issn.1006-3536.2010.z1.066

2010-01-01

Abstract:Why establish biological evaluation of biomaterials are described and standard system of biological eval-uation on medical devices (GB/T 16886) is introduced in this paper. Meanwhile, Up-to-date tendency of biological evalu-ation on biomaterials is elaborated.
Accelerating medical device biocompatibility evaluation: An industry perspective

K.P. Coleman,W.V. Christian,W. Zhang

DOI: https://doi.org/10.1016/b978-0-08-102643-4.00010-0

2020-01-01

Abstract:Determining what biological testing is required for the development and approval of a new medical device can be complex. Biological evaluation of medical devices is governed by standards such as ISO 10993, the Japanese Ministry of Health, Labor and Welfare Notifications and Ordinances, and China’s GB/T 16886 national standards. This chapter highlights the processes and steps involved in the evaluation of new medical devices and materials. It discusses how chemical characterization and toxicology data are used to evaluate risk and establish biocompatibility. A detailed overview of the development of biological evaluation plans and reports is described along with biological evaluations of combination products. In addition, information about new tools, special topics, and future trends are included. Plus, a list of sources for scientific, regulatory, and industry information is provided.
[Research Status of Nanomaterial Medical Device and Discussion on Biological Evaluation]

Lingxiao Sun,Min Wan,Xiaoxia Sun,Jia Liu,Xiaoxiao Gai,Guowei Wang,Wenting Ruan,Yang Qin,Chenghu Liu

DOI: https://doi.org/10.3969/j.issn.1671-7104.230286

2024-01-30

Abstract:In recent years, China has made great progress in basic nanomedicine, nanotoxicology and nanobiology research. Nanotechnology has been continuously applied in biomaterial and medical device, more and more medical devices applying nanomaterials are developed and manufactured. In order to gain more comprehension and accurate understanding of the research and industrial development in nanobiomaterial medical devices, this study reviewed the common nanomaterial in medical devices and the regulatory situation of nanomaterial medical devices at home and abroad, and discussed the current challenges in biological evaluation of nanomaterial medical devices, with a view to providing ideas for the safety evaluation and research of related products.
ISO 10993: Biological Evaluation of Medical Devices

Pugazhenthan Thangaraju,Shoban Babu Varthya

DOI: https://doi.org/10.1007/978-3-030-91855-2_11

2022-01-01

Abstract:The timely evaluation of the medical devices for biological safety is the need of the hour. The medical device regulation (MDR) in combination with the recent modification of ISO 10993 series into the assessment of the safety of medical devices biologically. The manufacturers need to follow all the approach in testing the devices before entering into the open market with their risk strategies. Right from the packing till it is inserted for its indented use in human, it has to be carefully tested and evaluated and is found to fit with the standard criteria. This chapter will throw insights in various aspects of biological evaluation of medical devices under each subheadings.
The Immunotoxicity Testing and Evaluation of the Medical Devices

WANG Chun-ren,XI Ting-fei

DOI: https://doi.org/10.3969/j.issn.1006-6586.2007.04.013

2007-01-01

Abstract:This paper reviewed the recent progress and requirement of the immunotoxicity of the medical devices. Especially presented a detailed introduction of the immunotoxicity definition, flow chart of the immunotoxicity testing, potential immunological effects of devices and constitute materials, classification of immune response associated with potential immunotoxic effects and examples of tests, indicators and models for the evaluation of immune response on the medical devices.
Review and approval of medical devices in China: Changes and reform

Wenbo Liu,Xinli Shi,Zhong Lu,Lanming Wang,Kai Zhang,Xingdong Zhang

DOI: https://doi.org/10.1002/jbm.b.34031

2017-10-28

Abstract:The 4th US-China Joint Workshop on Regulation, Standards and Innovation of Biomaterials was held during the Annual Meeting of the Society for Biomaterials on April 5, 2017 at Minneapolis, MN. This series of joint workshops have become a unique platform for both the US and China to discuss and update what is new in the field of biomaterials and medical devices in terms of regulation, standards and innovation since 2013. China Food and Drug Administration and its affiliated agencies such as Center for Medical Device Evaluation presented at each of the workshop. With the implementation of Regulations for the Supervision and Administration of Medical Devices (Decree of the State Council of the People's Republic of China, No. 650) since June 1, 2014, the regulatory changes and reform for medical devices in China have been hot topics in the workshops. This report captures the key information presented during the workshops, which includes major changes of the Chinese medical device regulation systems, reform of the review and approval system for medical devices in China, and the special procedures of review and approval for innovative medical devices. The market growth of medical devices along with demands for innovative technologies brings the ongoing regulatory changes and reform in China, which will certainly create positive impact on both the development of the Chinese healthcare system and the innovation of medical devices in China. © 2017 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 106B: 2093-2100, 2018.

engineering, biomedical,materials science, biomaterials
[Supervision, Administration and Standard Research Related to Tissue Engineered Medical Products].

Ting-fei Xi,Liang Chen,Peng Zhao

2003-01-01

Abstract:Tissue engineering advance in supplying the reparative and reconstructive medicine with promising tissue engineered medical products(TEMPs) and the new therapy alternative. The related supervision and administration of TEMPs is being developed and the standard research of TEMPs is also in progress. The Food and Drug Administration(FDA) of the United States has treated TEMPs as combined products and supervised them according to the level of risk to patients. Lately, FDA has determined that the Center for Devices and Radiological Health (CDRH) should take charge of examination and approval of TEMPs, with the cooperation of the Center for Biological Evaluations and Research(CBER). The regulatory controls have been established respectively in European Union and Japan. In China, TEMPs are identified as medical devices combined with cells. The Department of Medical Device of the State Food and Drug Administration (SFDA) is responsible for the examination and approval of TEMPs, and National Institute for the Control of Pharmaceutical & Biological Products(NICPBP) is responsible for evaluation tests. The standards of TEMPs are formulated mainly by the American Society of Testing Materials(ASTM) and International Standardization Organization(ISO).
The Current Situation and Developmental Trend of Biomedical Materials

Ting-fei XI

DOI: https://doi.org/10.3969/j.issn.1006-6586.2013.08.001

2006-01-01

Abstract:In the paper, we summarize the developmental process of biomedical materials, and put forward the development direction of bio-medical material in the future. Third-generation biomedical materials possess two properties: degradation and bioactivity, and it can help the body heal itself once implanted. Reproduction of tissue and organ in tissue engineering is a rapidly advancing filed that opens new and exciting opportunities of regenerative medicine and biomedical materials.
Research Progress in Mechanisms of Biocompatibility

DONG Zhe,XI Ting-fei

DOI: https://doi.org/10.3760/cma.j.issn.1673-4181.2011.01.014

2011-01-01

International Journal of Biomedical Engineering

Abstract:The interaction of biomaterials and tissues has been the focus of biomaterial science for many years and formed the foundation of the subject of biocompatibility. The research about biomaterials provides better basis for biomedical devices by the understanding of biocompatibility phenomena. In this paper, over 50 years of experience with such devices is analysed and it is shown that, in the vast majority of circumstances, the sole requirement for biocompatibility in a medical device intended for long-term contact with the tissues of the human body is that no harm should be brought to those tissues. Only a few bio-active biomaterials has been applied successfully in clinics. This artical gives a review on the application of biomaterials in tissue engineering,sophisticated cells, drug and gene delivery systems and in biotechnology. Interactions between biomaterials and tissue components is discussed as well.
Progress in the Studies on the Evaluation of Biocompatibility of Biomaterials

X Yang,T Xi

DOI: https://doi.org/10.3321/j.issn:1001-5515.2001.01.033

2001-01-01

Abstract:Biocompatibility remains the central theme for biomaterials applications in medicine. It generally refers to the compatibility between the biomaterials and the receptor, including tissue-compatibility and blood-compatibility. The definition of the biocompatibility has been greatly changed in recent years; it is now accepted as involving two principle areas, one is the principle of ‘biosafety’, the second is the principle of ‘biofunctiona lity’.
Biomedical materials and its industry status

Lina WEI,Zhen ZHENG,Tingfei XI

DOI: https://doi.org/10.19529/j.cnki.1672-6278.2018.01.01

2018-01-01

Journal of Biomedical Engineering Research

Abstract:Recently,biomedical materials develop rapidly and have been the focus of research and development.Its disciplinary development,industry status and development tendency are reviewed in this article.
Application and Development of Microelectronic Technology in Biology and Medicine

谢翔,张春,王志华

DOI: https://doi.org/10.3969/j.issn.1007-0249.2003.02.018

2003-01-01

Abstract:In the developing process, research on microelectronic technology and biology and medicine are always mutually stimulated. Based on the basic concept and the survey of current research situation, the interaction between two fields and the development in the biomedical electronics, such as biomedical sensor, nerve electrode, implantable electronic device, monitoring technology, biochip, molecule and biomolecular electronics and bionic device are reviewed. Up-to-date methodology is discussed and the developing trend of research is prospected.
Biomedical Engineering Education Development in China: Introduction of BME Program in Zhejiang University

XX Zheng,SR Xia

DOI: https://doi.org/10.1117/12.468697

2002-01-01

Abstract:Biomedical engineering is a newly developed interdisciplinary subject developed from the combination of modem life science, medical science and engineering. In this paper, the development of BME program in China is simply dealt with at first, and then BME program in Zhejiang University is presented, especially some effective and innovative acts which have been tested and proved in the process of education and training of undergraduates are emphatically introduced. A conclusion is reached at the end of this paper.
The current situation and development of medical device testing institutes in China

Xiaofang Yang,Ruihong Mu,Yubo Fan,Chunren Wang,Deyu Li

DOI: https://doi.org/10.1080/17434440.2017.1299572

Abstract:This article analyses the current situation and development of Chinese medical device testing institutes from the perspectives of the two most important functions - testing functions and medical device standardization functions. Areas Covered: The objective of the Chinese government regulations for medical device industry is to ensure the safety and effectiveness of medical devices for Chinese patients. To support the regulation system, the Chinese government has established medical device testing institutes at different levels for example, the national, provincial, and municipal levels. These testing institutes also play an important role in technical support during medical device premarket registration and post market surveillance, they are also the vital practitioners of Chinese medical device standardization. Expert Commentary: Chinese medical device testing institutes are technical departments established by government, and serve the regulatory functions of government agency. In recent years, with the rapid development of medical device industry as well as constantly increasing international and domestic medical device market, the importance of medical device testing institute is more prominent, However, there are still some problems unsolved, such as their overall capacity remains to be improved, construction of standardization is to be strengthened, etc.
Advances in Biomedical Engineering and Biotechnology During 2013–2014

Feng Li,Ying Wang,Timothy A. Burkhart,Manuel G. Penedo,Shuang Ma

DOI: https://doi.org/10.3233/bme-140998

2014-01-01

Bio-Medical Materials and Engineering

Abstract:The 3rd International Conference on Biomedical Engineering and Biotechnology (iCBEB 2014), held in Beijing from the 25th to the 28th of September 2014, is an annual conference that intends to provide an opportunity for researchers and practitioners around the world to present the most recent advances and future challenges in the fields of biomedical engineering, biomaterials, bioinformatics and computational biology, biomedical imaging and signal processing, biomechanical engineering and biotechnology, amongst others.The papers published in this issue are selected from this conference, which witnesses the advances in biomedical engineering and biotechnology during 2013-2014.
Analysis and Discussion of the Application of Mini-HTA in Medical Device Evaluation in the Hospital

Jun YANG,Wei JIN,Heng ZHANG

DOI: https://doi.org/10.3969/j.issn.1674-1633.2016.01.021

2016-01-01

Abstract:Since the medical devices play an increasingly important role in the field of health care, the reasonable allocation of medical devices has become a major problem faced by many hospitals. By evaluating the literature retrieved from the CNKI (China National Knowledge Infrastructure) and PubMed database, this paper made an inquiry into the related literature concerning hospital medical device management. The research also analyzed and explored the status quo of the health technology assessment of medical devices in the hospitals both at home and abroad.
[PROGRESS IN BIOLOGICAL TISSUE ENGINEERING SCAFFOLD MATERIALS].

Xiaojuan Wei,Tingfei Xi,Yufeng Zheng

DOI: https://doi.org/10.7507/1002-1892.20140173

2014-01-01

Abstract:OBJECTIVE:To analyze the progress in biological tissue engineering scaffold materials and the clinical application, as well as product development status.METHODS:Based on extensive investigation in the status of research and application of biological tissue engineering scaffold materials, a comprehensive analysis was made. Meanwhile, a detailed analysis of research and product development was presented.RESULTS:Considerable progress has been achieved in research, products transformation, clinical application, and supervision of biological scaffold for tissue engineering. New directions, new technology, and new products are constantly emerging. With the continuous progress of science and technology and continuous improvement of life sciences theory, the new direction and new focus still need to be continuously adjusted in order to meet the clinical needs.CONCLUSION:From the aspect of industrial transformation feasibility, acellular scaffolds and extracellular matrix are the most promising new growth of both research and product development in this field.
DEVELOPMENT AND TREND OF BIOMANUFACTURING

Yan Yongnian,Liu Haixia,Li Shengjie,Xiong Zhuo,Wang Xiaohong

DOI: https://doi.org/10.16262/j.cnki.1000-8217.2007.02.001

2007-01-01

Abstract:In this paper we make a thorough and systematic expatiation of the definition,connotation and com- position of biomanufacture.Based on the different development stages and process of bioengineering,its main re- search direction and corresponding researches were reviewed.Further,from the viewpoint of interdisciplinary, integration and development,the main technological development direction of bioengineering in the coming years were pointed out.
Next‐Generation Approaches for Biomedical Materials Evaluation: Microfluidics and Organ‐on‐a‐Chip Technologies

Yuxuan Li,Ke Sun,Yi Shao,Cheng Wang,Feng Xue,Chenglin Chu,Zhongze Gu,Zaozao Chen,Jing Bai

DOI: https://doi.org/10.1002/adhm.202402611

IF: 10

2024-10-25

Advanced Healthcare Materials

Abstract:This review systematically summarizes current biological evaluation methods, emphasizing the potential of microfluidic technologies and organ‐on‐a‐chip systems in material biological assessment. It provides a detailed discussion of the challenges and opportunities associated with employing organ‐on‐a‐chip systems in the field of material evaluation. Biological evaluation of biomedical materials faces constraints imposed by the limitations of traditional in vitro and animal experiments. Currently, miniaturized and biomimetic microfluidic technologies and organ‐on‐chip systems have garnered widespread attention in the field of drug development. However, their exploration in the context of biomedical material evaluation and medical device development remains relatively limited. In this review, a summary of existing biological evaluation methods, highlighting their respective advantages and drawbacks is provided. The application of microfluidic technologies in the evaluation of biomedical materials, emphasizing the potential of organ‐on‐chip systems as highly biomimetic in vitro models in material evaluation is then focused. Finally, the challenges and opportunities associated with utilizing organ‐on‐chip systems to evaluate biomedical materials in the field of material evaluation are discussed. In conclusion, the integration of advanced microfluidic technologies and organ‐on‐chip systems presents a potential paradigm shift in the biological assessment of biomedical materials, offering the prospective of more accurate and predictive in vitro models in the development of medical devices.

nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials

The Development of the Biological Evaluation on Medical Device in 2003

Expert Consensus on Quality Management System of Bioprinting Medical Devices Special Requirements

Biological evaluation standard and trial method of biomaterials

Accelerating medical device biocompatibility evaluation: An industry perspective

[Research Status of Nanomaterial Medical Device and Discussion on Biological Evaluation]

ISO 10993: Biological Evaluation of Medical Devices

The Immunotoxicity Testing and Evaluation of the Medical Devices

Review and approval of medical devices in China: Changes and reform

[Supervision, Administration and Standard Research Related to Tissue Engineered Medical Products].

The Current Situation and Developmental Trend of Biomedical Materials

Research Progress in Mechanisms of Biocompatibility

Progress in the Studies on the Evaluation of Biocompatibility of Biomaterials

Biomedical materials and its industry status

Application and Development of Microelectronic Technology in Biology and Medicine

Biomedical Engineering Education Development in China: Introduction of BME Program in Zhejiang University

The current situation and development of medical device testing institutes in China

Advances in Biomedical Engineering and Biotechnology During 2013–2014

Analysis and Discussion of the Application of Mini-HTA in Medical Device Evaluation in the Hospital

[PROGRESS IN BIOLOGICAL TISSUE ENGINEERING SCAFFOLD MATERIALS].

DEVELOPMENT AND TREND OF BIOMANUFACTURING

Next‐Generation Approaches for Biomedical Materials Evaluation: Microfluidics and Organ‐on‐a‐Chip Technologies